We are live on
!
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$268M
1-Year Est. Return
158.98%
This Fund
S&P 500
This Quarter
Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
(+7.9%)
Cap. Flow
-$39.5M
Cap. Flow
% of AUM
-27.17%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75
Top Buys
| 1 |
Centene
CNC
|
+$6.93M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.78M |
| 3 |
UnitedHealth
UNH
|
+$3.65M |
| 4 |
CVS Health
CVS
|
+$3.53M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$3.17M |
Top Sells
| 1 |
Humana
HUM
|
+$4.91M |
| 2 |
Encompass Health
EHC
|
+$3.58M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$3.43M |
| 4 |
Amgen
AMGN
|
+$3.35M |
| 5 |
Eli Lilly
LLY
|
+$2.53M |
Sector Composition
| 1 | Healthcare | 48.9% |
| 2 | Financials | 13.82% |
| 3 | Technology | 6.61% |
| 4 | Consumer Discretionary | 5.8% |
| 5 | Materials | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CALL
SoFi Technologies
SOFI
$22.2B
| – | – |
-200
| Closed | -$10.5K |
|
302
CALL
ARS Pharmaceuticals
SPRY
$695M
| – | – |
-646
| Closed | -$248K |
|
303
Scholar Rock
SRRK
$6.33B
| – | – |
-14,314
| Closed | -$501K |
|
304
CALL
Tango Therapeutics
TNGX
$4.65B
| – | – |
-461
| Closed | -$55.4K |
|
305
CALL
Uber
UBER
$147B
| – | – |
-160
| Closed | -$46.1K |
|
306
UMB Financial
UMBF
$11.1B
| – | – |
-9,391
| Closed | -$988K |
|
|
VBTX
307
DELISTED
Veritex Holdings
VBTX
| – | – |
-7,980
| Closed | -$208K |
|
308
Viridian Therapeutics
VRDN
$1.99B
| – | – |
-28,032
| Closed | -$392K |
|
309
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-2,303
| Closed | -$1.03M |
|
310
Zillow
Z
$7.76B
| – | – |
-3,071
| Closed | -$215K |
|
311
Zai Lab
ZLAB
$2.28B
| – | – |
-873
| Closed | -$30.5K |
|
312
Flutter Entertainment
FLUT
$18.5B
| – | – |
-2,183
| Closed | -$624K |
|
313
Reddit
RDDT
$34.9B
| – | – |
-3,000
| Closed | -$452K |
|
|
ZK
314
DELISTED
Zeekr
ZK
| – | – |
-10,000
| Closed | -$255K |
|
|
NBIS
315
CALL
Nebius Group N.V.
NBIS
$45.1B
| – | – |
-140
| Closed | -$53.6K |
|
Similar funds
VC
AL
FC
NF
PF
UI
SSWM
AC
Persistent Asset Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.
Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.
- Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
- Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
- Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
- Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
- Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
- Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
- Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.
Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.